Viewing Study NCT01844232


Ignite Creation Date: 2025-12-24 @ 9:55 PM
Ignite Modification Date: 2026-06-06 @ 6:14 PM
Study NCT ID: NCT01844232
Status: COMPLETED
Last Update Posted: 2022-04-25
First Post: 2013-04-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity
Sponsor: RVL Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis View
None Spasticity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple sclerosis View
None spasticity View
None arbaclofen View